Stephanie Young Moss, PharmD Medical Reviewer Stephanie Young Moss, PharmD, has worked in pharmacy, community outreach, regulatory compliance, managed care, and health economics and outcomes research
Overall, the integration of GLP 1 agonists into the management strategies for diabetes and obesity marks significant progress within medical research
One medication of growing interest to our patients is Ozempic, which contains the active ingredient semaglutide
coli and S
Schedule your free consultation with our expert medical team and discover how our personalized approach can help you succeed
Regulatory Update (April 2026): DSIP (also referred to as Emideltide) is one of seven peptides scheduled for FDA Pharmacy Compounding Advisory Committee review on July 24, 2026